|Last Price$105.00||Day Change (%)-0.61%|
|Open Price$105.40||Day Change ($)-0.64|
|Day Range104.94–105.70||52-Week Range76.76–110.13|
As of Thu 12/12/2013 04:40 PM EST | USD
BD to Present at the 25th Annual Piper Jaffray Healthcare Conference
Research and Markets: Injectable Drug Delivery in North America - Market Report 2013 - 2017
Research and Markets: Germany Diabetes Management Devices Market Growth and Forecast To 2018
Research and Markets: France Diabetes Management Devices Market Growth Trends, 2013
This screen finds companies ready to take advantage when major provisions of law take effect in 2014.
Four offerings deemed to be right for right now.
A retailer's attractive pricing and a health-care firm's favorable prospects create solid growth opportunities for Jensen manager Eric Schoenstein.
Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.
While we remain bullish on the sector, health-care growth depends on the economy.